Horizon Discovery (China) Ltd.
GPTKB entity
Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:PerkinElmer,_Inc.
|
| gptkbp:awards |
Innovation Award 2021
Excellence in Research 2019 Best_Biotechnology_Company_2020 |
| gptkbp:CEO |
gptkb:Dr._Darrin_Disley
|
| gptkbp:collaboratesWith |
Research Institutions
Biotech_Firms |
| gptkbp:communityEngagement |
Public Awareness Campaigns
STEM Education Programs Local Health Initiatives |
| gptkbp:financials |
Revenue Growth 15% 2022
Funding Rounds 2021 Investment_from_Venture_Capitalists Profit_Margin_20%_2022 |
| gptkbp:focusArea |
Precision Medicine
Genomic_Research |
| gptkbp:foundedIn |
2015
|
| gptkbp:futurePlans |
Increase R&D Investment
Develop_New_Therapeutics Expand_Operations_in_Asia |
| gptkbp:hasTheme |
CRISPR Applications
Gene_Editing_Techniques Cell_Line_Technologies |
| gptkbp:headquarters |
gptkb:China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery (China) Ltd.
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:offersServices |
gptkb:CRISPR_Technology
Genetic Engineering Cell_Line_Development Gene_Synthesis |
| gptkbp:operatesIn |
gptkb:Asia
|
| gptkbp:parentCompany |
gptkb:Horizon_Discovery_Group_plc
|
| gptkbp:partnerships |
Pharmaceutical Companies
Various Academic Institutions |
| gptkbp:researchFocus |
gptkb:Cancer_Research
Genetic Disorders Therapeutic Development |
| gptkbp:specializesIn |
Gene Editing
|
| gptkbp:sustainabilityInitiatives |
Energy Efficiency Measures
Waste Reduction Programs Green Lab Practices |
| gptkbp:targetMarket |
Academic Institutions
Pharmaceutical Companies Research Organizations |
| gptkbp:website |
www.horizondiscovery.com
|